with multiple hydrophobic residues for spanning membranes. 9 Bioinformatics analysis predicted an overrepresentation of TMHs among strong, high-affinity MHC class I binding epitopes, 9 which therefore represent a large antigen repertoire for targeting highaffinity CD8 T cells. To confirm this, we chose a murine-free fatty acid receptor 1 (GPR40; Fig. 1a ) that is expressed in murine and human beta cells. 10 Indeed, a single injection of pCI/GPR40, but not of empty pCI DNA into RIP-B7.1 mice, induced hyperglycemia and autoimmune diabetes ( Fig. 1b ). Hyperglycemia was reversed in pCI/GPR40-immune diabetic RIP-B7.1 mice (with blood glucose levels between 370 and 400 mg/dl) by two consecutive injections of anti-CD8 antibodies, but not anti-CD4 antibodies (Fig. 1c ). 6 In line with this finding, diabetes development was characterized by a continuous infiltration of islets by CD8 T cells, a concomitant destruction of beta cells and decreased production of insulin ( Fig. 1d ). CD8 T cells were thus crucial for GPR40-induced diabetes in RIP-B7.1 mice.
The GPR40 receptor molecule comprises seven transmembrane domains ( Fig. 1a ). To map MHC I epitopes, we generated four overlapping GPR40 fragment-encoding expression vectors ( Fig. 1e ). Only pCI/GPR40 150-237 induced autoimmune diabetes in RIP-B7.1 mice (Fig. 1e ). The GPR40 150-237 fragment contained a GPR 187-195 sequence in a hydrophobic TMH with two potential K b epitopes, both with anchor residues F at position 5 and L at position 8 or 7/9 [SILLFFLPL and ILLFFLPL]. We identified the SILLFFLPL antigenic epitope ( Supplementary Fig. S1 ) and used this peptide to assemble K b /GPR 187-195 tetramers. With this tool, we were able to directly detect K b /GPR 187-195 -specific CD8 T cells in the pancreata of pCI/GPR40 150-237 -immune and diabetic RIP-B7.1 mice, but not in the pancreata of pCI-injected healthy control mice ( Fig. 1f ). Notably, we identified another autoreactive CD8 T-cell response in pCI/GPR40 226-300 -immune and diabetic BALB-RIP-B7.1 mice that was directed against a D d /GPR40 236-244 epitope localized to a different TMH ( Fig. 1a ; Supplementary Fig. S2 ).
The injection of pCI/ppins, 6, 7 but not of pCI/GPR40, into PD-L1 −/− mice induced autoimmune diabetes ( Fig. 1g ). We could not detect K b /GPR 187-195 -specific IFN-γ + producing effector CD8 T cells in the spleens of healthy mice up to 3 months post immunization ( Fig. 1h ). However, we detected transient K b /GPR 187-195 -specific tetramer + CD8 T-cell populations in the pancreas~day 12 Fig. 1 a Illustration of murine GPR40 and its seven transmembrane domains (swissprot. acc. no: Q76JU9). In addition, the localization of the newly identified K b /GPR40 187-195 and D d /GPR40 236-244 epitopes in TMHs is shown. b RIP-B7.1 mice were injected with pCI (triangles; n = 5) or pCI/GPR40 DNA (circles; n = 5), and blood glucose levels and diabetes incidence (%) were determined over time. c Four GPR40-immune and diabetic RIP-B7.1 mice were injected twice with anti-CD8 antibodies (open circles; n = 2) and anti-CD4 antibodies (closed circles; n = 2), and blood glucose levels were measured in individual mice for 5 days. d Pancreatic sections from representative healthy and diabetic RIP-B7.1 mice were stained for insulin (middle panels) and CD8 T cells (left panels). e RIP-B7.1 mice (n = 3-4 per group) were injected with pCI/ GPR40 1-87, pCI/GPR40 74-162 , pCI/GPR40 150-237 and pCI/GPR40 226-300 vectors, and diabetes incidence was determined over time. f GPR40 187-195 -specific tetramer + CD8 T cells in the pancreata of healthy, pCI-immune (n = 3) and pCI/GPR40 150-237 -immune diabetic (n = 5) RIP-B7.1 mice were analyzed by FCM. The mean percentage of GPR40 187-195 -specific tetramer + CD8 T cells ± SD is shown. In addition, representative dot blots for each group are shown. g PD-L1 −/− mice were injected with pCI/GPR40 (n = 5; upper panel) or coinjected with pCI/ GPR40 and pCI/ppins (n = 5; lower panel) and diabetes incidence was determined over time. h, i PD-L1 −/− mice (n = 4-5) were injected with pCI (group 1) or pCI/GPR40 (group 2) or coinjected with pCI/GPR40 and pCI/ppins into the left and right tibialis anterior muscle (group 3). h Healthy mice were analyzed day 12 post immunization for IFN-γ + GPR40 187-195 -specific CD8 T cells in the spleen and tetramer + CD8 T cells in the pancreas by FCM. i At the time of diabetes onset in group 3 (i.e., 4 weeks post immunization), IFN-γ + ppins/(K b /A 12-21 )-, and IFN-γ + K b / GPR40 187-195 -specific CD8 T cells in the spleen and tetramer + K b /GPR40-specific CD8 T cells in the pancreata were determined by FCM. h, i The mean percentages of IFN-γ + and tetramer + CD8 T cells ± SD are shown. Statistical differences between groups 1 and 2 and between groups 1 and 3 were determined by unpaired Student's t test, and p values < 0.05 (*) and < 0.01 (**) were considered significant. ns, not significant postpriming (Fig. 1h ). K b /GPR 187-195 -specific CD8 T cells were thus primed in PD-L1 −/− mice, but they did not acquire a functional IFN-γ + effector phenotype 8 and were rapidly eliminated in pCI/ GPR40-immune PD-L1 −/− mice. In contrast, PD-L1 −/− mice coinjected with pCI/ppins and pCI/GPR40 vectors developed early and severe autoimmune diabetes that correlated with the presence of circulating IFN-γ + ppins/(K b /A 12-21 )-specific CD8 T cells in the spleen (Fig. 1g, i) . Most interestingly, we also detected IFN-γ + K b /GPR 187-195 -specific effector CD8 T cells in the spleens and tetramer + CD8 T cells in pancreata of these diabetic mice (Fig. 1i) . As IFN-γ + K b /GPR 187-195 -specific CD8 T cells were detectable in pCI/ppins + pCI/GPR40, mice but not in pCI/GPR40-immune PD-L1 −/− mice, their expansion and activation into IFN-γ + effector T cells must be induced by events initiated by ppins/K b /A 12-21 -specific CD8 T cells. These findings confirm the crucial role of immunodominant autoreactive CD8 T cells as high-priority targets for novel disease mitigating vaccine strategies.
Our work adds GPR40 to the list of potential autoantigens in immune-mediated T1D. GPR40 is an important component in the fatty acid augmentation of insulin secretion 10 and is therefore directly linked to the functionality of pancreatic beta cells. As a key sensor of the intraislet milieu, GPR40 may be a novel marker of islet cell autoimmunity and may therefore become a predictive marker for T1D. In particular, the interplay between insulin-and GPR40-directed autoreactivity could also shed more light on the complex events involved in the pathogenesis of immunemediated diabetes.
